Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Lung Cancer

  Free Subscription

Articles published in Mol Carcinog

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    October 2020
  1. CHEN T, Tsang JYS, Su XC, Li P, et al
    SALL4 promotes tumor progression in breast cancer by targeting EMT.
    Mol Carcinog. 2020;59:1209-1226.
    PubMed     Abstract available

    September 2020
  2. HAN X, Liu X, Wang X, Guo W, et al
    TNF-alpha-dependent lung inflammation upregulates superoxide dismutase-2 to promote tumor cell proliferation in lung adenocarcinoma.
    Mol Carcinog. 2020;59:1088-1099.
    PubMed     Abstract available

    August 2020
  3. ZHAO X, Wu X, Wang H, Yu H, et al
    USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
    Mol Carcinog. 2020;59:1000-1011.
    PubMed     Abstract available

  4. REN P, Hong X, Chang L, Xing L, et al
    USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Mol Carcinog. 2020;59:875-885.
    PubMed     Abstract available

    July 2020
  5. ISHII H, Park WY, So J, Kuhn S, et al
    Loss of myeloid-specific lamin A/C drives lung metastasis through Gfi-1 and C/EBPepsilon-mediated granulocytic differentiation.
    Mol Carcinog. 2020;59:679-690.
    PubMed     Abstract available

    May 2020
  6. XU L, Xu F, Kong Q, Yang T, et al
    Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Mol Carcinog. 2020 May 19. doi: 10.1002/mc.23215.
    PubMed     Abstract available

  7. GAO Y, Luo L, Xie Y, Zhao Y, et al
    PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Mol Carcinog. 2020;59:503-511.
    PubMed     Abstract available

    April 2020
  8. CHEN L, Li L, Zhou C, Chen X, et al
    Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier.
    Mol Carcinog. 2020;59:390-398.
    PubMed     Abstract available

    March 2020
  9. ZHANG Q, Chen M, Cao L, Ren Y, et al
    Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Mol Carcinog. 2020 Mar 18. doi: 10.1002/mc.23184.
    PubMed     Abstract available

  10. WANG Q, Yang G, Jiang Y, Luo M, et al
    XB130, regulated by miR-203, miR-219, and miR-4782-3p, mediates the proliferation and metastasis of non-small-cell lung cancer cells.
    Mol Carcinog. 2020 Mar 11. doi: 10.1002/mc.23180.
    PubMed     Abstract available

    February 2020
  11. WANG B, Pan LY, Kang N, Shen XY, et al
    PP4R1 interacts with HMGA2 to promote non-small-cell lung cancer migration and metastasis via activating MAPK/ERK-induced epithelial-mesenchymal transition.
    Mol Carcinog. 2020 Feb 19. doi: 10.1002/mc.23168.
    PubMed     Abstract available

  12. LU X, Guan A, Chen X, Xiao J, et al
    mPRalpha mediates P4/Org OD02-0 to improve the sensitivity of lung adenocarcinoma to EGFR-TKIs via the EGFR-SRC-ERK1/2 pathway.
    Mol Carcinog. 2020;59:179-192.
    PubMed     Abstract available

  13. LI YH, Xu CL, He CJ, Pu HH, et al
    circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
    Mol Carcinog. 2020;59:141-153.
    PubMed     Abstract available

    November 2019
  14. TANG D, Zhao YC, Qian D, Liu H, et al
    Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.
    Mol Carcinog. 2019 Nov 12. doi: 10.1002/mc.23132.
    PubMed     Abstract available

  15. LEE MJ, Kuehne N, Hueniken K, Liang S, et al
    Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
    Mol Carcinog. 2019;58:1960-1973.
    PubMed     Abstract available

    October 2019
  16. WANG Y, Ding X, Liu B, Li M, et al
    ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
    Mol Carcinog. 2019 Oct 31. doi: 10.1002/mc.23130.
    PubMed     Abstract available

  17. TSUBOI M, Kondo K, Soejima S, Kajiura K, et al
    Chromate exposure induces DNA hypermethylation of the mismatch repair gene MLH1 in lung cancer.
    Mol Carcinog. 2019 Oct 3. doi: 10.1002/mc.23125.
    PubMed     Abstract available

    September 2019
  18. SUN W, Hu S, Zu Y, Deng Y, et al
    KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer.
    Mol Carcinog. 2019 Sep 5. doi: 10.1002/mc.23072.
    PubMed     Abstract available

    August 2019
  19. CUI J, Yin Z, Liu G, Chen X, et al
    Activating transcription factor 1 promoted migration and invasion in lung cancer cells through regulating EGFR and MMP-2.
    Mol Carcinog. 2019 Aug 16. doi: 10.1002/mc.23086.
    PubMed     Abstract available

  20. FU Y, Su L, Cai M, Yao B, et al
    Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.
    Mol Carcinog. 2019 Aug 9. doi: 10.1002/mc.23095.
    PubMed     Abstract available

    May 2019
  21. XU L, Qiu S, Yang L, Xu H, et al
    Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.
    Mol Carcinog. 2019 May 8. doi: 10.1002/mc.23038.
    PubMed     Abstract available

  22. MA W, Ho DW, Sze KM, Tsui YM, et al
    APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.
    Mol Carcinog. 2019;58:643-653.
    PubMed     Abstract available

    April 2019
  23. SUN Q, Wang Y, Fan J, Li Z, et al
    Association of expression quantitative trait loci for long noncoding RNAs with lung cancer risk in Asians.
    Mol Carcinog. 2019 Apr 26. doi: 10.1002/mc.23013.
    PubMed     Abstract available

  24. GUO Y, Feng Y, Liu H, Luo S, et al
    Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Mol Carcinog. 2019 Apr 15. doi: 10.1002/mc.23017.
    PubMed     Abstract available

    March 2019
  25. YOO SM, Lee CJ, Kang HC, Lee HS, et al
    Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Mol Carcinog. 2019 Mar 18. doi: 10.1002/mc.23005.
    PubMed     Abstract available

  26. HAN X, Dong Q, Wu J, Luo Y, et al
    RASSF10 suppresses lung cancer proliferation and invasion by decreasing the level of phosphorylated LRP6.
    Mol Carcinog. 2019 Mar 4. doi: 10.1002/mc.23000.
    PubMed     Abstract available

  27. LAWSON J, Dickman C, Towle R, Jabalee J, et al
    Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication.
    Mol Carcinog. 2019;58:376-387.
    PubMed     Abstract available

    February 2019
  28. DING Z, Zhu J, Zeng Y, Du W, et al
    The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
    Mol Carcinog. 2019 Feb 27. doi: 10.1002/mc.22990.
    PubMed     Abstract available

  29. CHEN W, Do KC, Saxton B, Leng S, et al
    Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small cell lung cancer cells.
    Mol Carcinog. 2019 Feb 20. doi: 10.1002/mc.22992.
    PubMed     Abstract available

  30. SUMARDIKA IW, Chen Y, Tomonobu N, Kinoshita R, et al
    Mol Carcinog. 2019 Feb 5. doi: 10.1002/mc.22987.
    PubMed     Abstract available

  31. LI X, Fu Q, Zhu Y, Wang J, et al
    CD147-mediated glucose metabolic regulation contributes to the predictive role of (18) F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC.
    Mol Carcinog. 2019;58:247-257.
    PubMed     Abstract available

    January 2019
  32. LI Y, Xiang C, Shen N, Deng L, et al
    Functional polymorphisms on chromosome 5p15.33 disturb telomere biology and confer the risk of non-small cell lung cancer in Chinese population.
    Mol Carcinog. 2019 Jan 25. doi: 10.1002/mc.22980.
    PubMed     Abstract available

  33. ZHANG X, Han S, Zhou H, Cai L, et al
    TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Mol Carcinog. 2019 Jan 3. doi: 10.1002/mc.22969.
    PubMed     Abstract available

    December 2018
  34. LIU WB, Han F, Huang YS, Chen HQ, et al
    TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
    Mol Carcinog. 2018 Dec 11. doi: 10.1002/mc.22942.
    PubMed     Abstract available

    October 2018
  35. SONG JM, Im J, Nho RS, Han YH, et al
    Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Mol Carcinog. 2018 Oct 26. doi: 10.1002/mc.22930.
    PubMed     Abstract available

  36. JIAN M, Yunjia Z, Zhiying D, Yanduo J, et al
    Interleukin 7 Receptor Activates PI3K/Akt/mTOR Signaling Pathway via Downregulation of Beclin-1 in Lung Cancer.
    Mol Carcinog. 2018 Oct 26. doi: 10.1002/mc.22933.
    PubMed     Abstract available

    September 2018
  37. FENG Y, Gao Y, Yu J, Jiang G, et al
    CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.
    Mol Carcinog. 2018 Sep 22. doi: 10.1002/mc.22914.
    PubMed     Abstract available

    August 2018
  38. CHEN QY, Li J, Sun H, Wu F, et al
    Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.
    Mol Carcinog. 2018;57:968-977.
    PubMed     Abstract available

    June 2018
  39. WU GJ, Pen J, Huang Y, An S, et al
    KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
    Mol Carcinog. 2018 Jun 19. doi: 10.1002/mc.22853.
    PubMed     Abstract available

  40. BORREGO A, Cabrera WHK, Jensen JR, Correa M, et al
    Germline control of somatic Kras mutations in mouse lung tumors.
    Mol Carcinog. 2018;57:745-751.
    PubMed     Abstract available

    May 2018
  41. LI Z, Fan J, Li N, Zhu M, et al
    Fine mapping in TERT-CLPTM1L region identified three independent lung cancer susceptibility signals: a large-scale multi-ethnic population study.
    Mol Carcinog. 2018 May 29. doi: 10.1002/mc.22843.
    PubMed     Abstract available

  42. WANG S, Cheng Y, Gao Y, He Z, et al
    SH2B1 promotes epithelial-mesenchymal transition through the IRS1/beta-catenin signaling axis in lung adenocarcinoma.
    Mol Carcinog. 2018;57:640-652.
    PubMed     Abstract available

    March 2018
  43. YANG Y, Sun Y, Wu Y, Tang D, et al
    Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer.
    Mol Carcinog. 2018 Mar 22. doi: 10.1002/mc.22805.
    PubMed     Abstract available

    January 2018
  44. SU YC, Chang H, Sun SJ, Liao C, et al
    Differential Impact of CX3CL1 on Lung Cancer Prognosis in Smokers and Non-smokers.
    Mol Carcinog. 2018 Jan 30. doi: 10.1002/mc.22787.
    PubMed     Abstract available

    December 2017
  45. WANG H, Wang L, Cao L, Zhang Q, et al
    Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
    Mol Carcinog. 2017 Dec 26. doi: 10.1002/mc.22777.
    PubMed     Abstract available

    November 2017
  46. YANG L, Lin Z, Wang Y, Gao S, et al
    MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
    Mol Carcinog. 2017 Nov 16. doi: 10.1002/mc.22765.
    PubMed     Abstract available

    October 2017
  47. FENG Y, Wang Y, Liu H, Liu Z, et al
    Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.
    Mol Carcinog. 2017 Oct 26. doi: 10.1002/mc.22748.
    PubMed     Abstract available

  48. PAN Z, Liu L, Nie W, Miggin S, et al
    Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.
    Mol Carcinog. 2017 Oct 25. doi: 10.1002/mc.22756.
    PubMed     Abstract available

  49. TAO S, de la Vega MR, Chapman E, Ooi A, et al
    The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer.
    Mol Carcinog. 2017 Oct 4. doi: 10.1002/mc.22745.
    PubMed     Abstract available

    September 2017
  50. LI Y, Zhang H, Li Y, Zhao C, et al
    MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Mol Carcinog. 2017 Sep 21. doi: 10.1002/mc.22741.
    PubMed     Abstract available

  51. HAN Y, Tang Z, Zhao Y, Li Q, et al
    TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Mol Carcinog. 2017 Sep 19. doi: 10.1002/mc.22740.
    PubMed     Abstract available

  52. ZHAO H, Zhang D, Yang L, Wang E, et al
    p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
    Mol Carcinog. 2017 Sep 12. doi: 10.1002/mc.22734.
    PubMed     Abstract available

    July 2017
  53. ZHANG X, Cai L, Zhou H, Liu Y, et al
    Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22700.
    PubMed     Abstract available

  54. YOU BR, Park WH
    Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22701.
    PubMed     Abstract available

    May 2017
  55. ZHU X, Li D, Zhang Z, Zhu W, et al
    Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.
    Mol Carcinog. 2017;56:1449-1460.
    PubMed     Abstract available

    April 2017
  56. ERDEM JS, Arnoldussen YJ, Skaug V, Haugen A, et al
    Copy number variation, increased gene expression and molecular mechanisms of Neurofascin in lung cancer.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22664.
    PubMed     Abstract available

  57. ZHOU C, Chen T, Xie Z, Qin Y, et al
    RACK1 Forms a Complex with FGFR1 and PKM2 and Stimulates the Growth and Migration of Squamous Lung Cancer Cells.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22663.
    PubMed     Abstract available

  58. XIE M, Wu X, Zhang J, Zhang J, et al
    Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22661.
    PubMed     Abstract available

  59. ZHANG X, Zhou H, Cai L, Fan C, et al
    Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22660.
    PubMed     Abstract available

    March 2017
  60. CHAE DK, Ban E, Yoo YS, Kim EE, et al
    MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Mol Carcinog. 2017 Mar 31. doi: 10.1002/mc.22655.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.